Lilly targets six US firms over black-market obesity drug
Anabelle Colaco
13 Aug 2026, 17:10 GMT+10
- Eli Lilly has filed lawsuits against six U.S. companies it accuses of illegally selling black-market versions of its experi<a href="https://healthylife7.com/the-mental-trap-that-keeps-us-solving-the-wrong-problem/” title=”The Mental Trap That Keeps Us Solving the Wrong Problem”>mental obesity drug retatrutide
- The lawsuits target businesses including compounding pharmacies, medical spas and online sellers that allegedly marketed retatrutide products to consumers even though the drug remains under clinical development
- Retatrutide is currently in Phase 3 clinical trials for obesity, type 2 diabetes and other related conditions
SAN FRANCISCO, California: Eli Lilly has filed lawsuits against six U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide, stepping up action against unauthorized sellers before the medicine has received regulatory approval
The lawsuits target businesses including compounding pharmacies, medical spas and online sellers that allegedly marketed retatrutide products to consumers even though the drug remains under clinical development
Retatrutide is currently in Phase 3 clinical trials for obesity, type 2 diabetes and other related conditions. Lilly said the compound has not been approved for human use by any regulator
In June, the U.S. Food and Drug Administration said sales of retatrutide and other unapproved versions of GLP-1 products to consumers are illegal and that the products cannot lawfully be compounded
“What is being sold on the black market is not a medicine – it is entirely unverified, unapproved and not worth the risk,” Lilly Chief Medical Officer Dr. David Hyman said in a statement
Lilly said demand for obesity treatments has fueled an online market for products claiming to contain weight-loss drugs. According to the company, some sellers have marketed retatrutide through websites, social media posts and businesses presenting themselves as medical providers despite sourcing products from unregulated manufacturers
The drugmaker said it has referred more than 200 individuals and entities to the FDA, the U.S. Justice Department, state attorneys general, law enforcement agencies and professional licensing boards
Lilly also called on social media and e-commerce platforms, payment processors, credit card companies, shipping firms and regulators to take stronger action against sellers of unapproved retatrutide products
U.S. Customs and Border Protection told Reuters that it intercepted more than 690 shipments containing over 31,000 units of illicit GLP-1 drugs during fiscal 2025. In July, the figures more than doubled, with more than 1,400 seizures and nearly 90,000
“Every single time that someone takes one of these, they’re exposing themselves to a huge amount of risk,” said Lilly’s Dr. Max Denning, Associate Vice President, Therapeutic Area Lead – Global Patient Safety Cardiometabolic Health
The six lawsuits were filed against Aesthetic Envy Cosmetic Centers, Astra LLC, Legendary Peptides, Striker Pharmacy, Texas Peptides and Lone Star Peptide Co
Watch latest videos
News RELEASES
Publish news of your business, community or sports group,
personnel appointments, major event and more by submitting a
news release to India Gazette
More Information
Business
Section
Lilly targets six US firms over black-market obesity drug
SAN FRANCISCO, California: Eli Lilly has filed lawsuits against six U.S. companies it accuses of illegally selling black-market versions
ECB sees no grounds to block UniCredit-Commerzbank deal
FRANKFURT, Germany: The European Central Bank is leaning toward approving UniCredit’s proposed takeover of Germany’s Commerzbank, according
Ireland spends over 1 million euros on tourism Influencers
DUBLIN, Ireland: Ireland’s tourism agencies have spent more than 1 million euros paying influencers, celebrities and online content
Disney+ to stream Formula E globally under new multi-year deal
BURBANK, California: Disney has secured the global streaming rights for Formula E under a new multi-year agreement that will bring
U.S. stocks end divided as CPI reading comes in as expected
NEW YORK, New York – U.S. stock markets delivered a split performance to close the midweek session, following Wednesday’s as-expected
Intel secures $20 billion to fund foundry growth amid AI demand
SANTA CLARA, California: Intel has raised US$20 billion through an upsized share offering as the chipmaker seeks to fund the expansion
Delhi
Section
Daimler India Commercial Vehicles signs Rs 4,000 crore MoU with Tamil Nadu govt to expand BharatBenz operations
New Delhi [India], August 13 (ANI): Daimler India Commercial Vehicles (DICV) outlined a fresh investment of approximately Rs 4,000
Rahul Gandhi moves SC against Allahabad HC order in disproportionate of assets case
New Delhi [India], August 13 (ANI): Leader of Opposition in the Lok Sabha Rahul Gandhi has moved the Supreme Court against orders passed
“Last chance”: SC warns Centre it will pass directions if FSSAI fails to implement front-of-pack warning labels
New Delhi [India], August 23 (ANI): The Supreme Court on Thursday came down heavily on the Central government and the Food Safety and
Gem, jewellery exports rise 2.44% to USD 9.17 bn in Apr-Jul, studded gold up 21%
New Delhi [India], August 13 (ANI): India’s gross gem and jewellery exports rose 2.44 per cent in US dollar terms to USD 9.17 billion
CISF’s Shruti Joshi wins team sabre gold at Commonwealth Fencing Championships
New Delhi [India], August 13 (ANI): Central Industrial Security Force (CISF) sportsperson Shruti Joshi added a gold medal to her individual
Union Minister Amit Shah hoists Tiranga at his residence under Har Ghar Tiranga campaign
New Delhi [India], August 13 (ANI): Ahead of Independence Day celebrations, Union Home Minister Amit Shah on Thursday hoisted the Tiranga
